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One of the key drivers of antibiotic resistance (ABR) and drug-resistant bacterial infections is the misuse and
overuse of antibiotics in human populations. Infection management and antibiotic decision-making are multi-
factorial, complex processes influenced by context and involving many actors. Social constructs including race,
ethnicity, gender identity and cultural and religious practices as well as migration status and geography
influence health. Infection and ABR are also affected by these external drivers in individuals and populations
leading to stratified health outcomes. These drivers compromise the capacity and resources of healthcare serv-
ices already over-burdened with drug-resistant infections. In this review we consider the current evidence and
call for a need to broaden the study of culture and power dynamics in healthcare through investigation of rela-
tive power, hierarchies and sociocultural constructs including structures, race, caste, social class and gender
identity as predictors of health-providing and health-seeking behaviours. This approach will facilitate a more sus-
tainable means of addressing the threat of ABR and identify vulnerable groups ensuring greater inclusivity in
decision-making. At an individual level, investigating how social constructs and gender hierarchies impact clinical
team interactions, communication and decision-making in infection management and the role of the patient
and carers will support better engagement to optimize behaviours. How people of different race, class and
gender identity seek, experience and provide healthcare for bacterial infections and use antibiotics needs to be
better understood in order to facilitate inclusivity of marginalized groups in decision-making and policy.
The persisting challenge of antibiotic
resistance
Antibiotic resistance (ABR) is an intractable problem that remains a
persistent challenge to global health security. It is driven by anti-
biotic use in human and animal populations, both of which are
consequences of a complex mix of social, economic and context-
ual factors.1,2
Existing efforts to address ABR focus primarily on interventions
that are not easily scalable, as they fail to consider the complex
inter-relationships between infection, antibiotic use and the emer-
gence and spread of resistance through a sociocultural lens.3 A
sociocultural perspective can help make sense of the wider set of
cultural and societal factors which not only influence ABR but also
the availability and allocation of resources and the capacity dedi-
cated to efforts to respond to this public health threat. Gaps in cap-
acity and resources significantly affect those populations most
vulnerable to the consequences of ABR.4 Moreover, by failing to
consider different contexts, existing efforts may be ignoring or con-
tributing to the societal inequities that drive ABR.
Reflecting these concerns, in 2015 the World Health Assembly
endorsed a global action plan on antimicrobial resistance calling
for the development and implementation of national action plans
(NAPs).5 Progress towards implementing effective strategies is,
however, impeded by the unequal risks and opportunities within
and across countries. If we are to tackle ABR effectively we need to
understand and address these inequalities and their consequen-
ces.6 To do so, we need to consider the diverse sociocultural and
political contexts in which ABR emerges and spreads. We must
identify those communities and individuals, many already disad-
vantaged and in low- and middle-income countries (LMICs), who
are at greatest risk. Disadvantaged populations may have greater
risks associated with ABR for several reasons. First, their burden of
infection is highest,7,8 placing them at greatest risk of what may
become effectively untreatable infections.9 Second, they may
struggle to obtain access to vaccination programmes that reduce
VC The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/













r/article/3/4/dlab123/6378246 by London School of H
ygiene & Tropical M
edicine user on 16 N
ovem
ber 2021
the risk of disease.10 Third, they are often exposed to conditions
that promote the emergence and spread of ABR, including inter-
rupted, inadequate or inappropriate treatment, dependent on
antibiotics supplied via informal outlets without the need for a
prescription.11
While the impact of socioeconomic inequalities on health has
received some attention in high-income countries(HICs), such as
the USA and the UK,12–14 there is very little evidence from else-
where. A study investigating the association between educational
attainment of NHS patients and their use of health services found
that higher education was positively associated with greater use of
outpatient care.12 This indicates that better educated patients are
better able to navigate the health system and access services
more effectively. The concept of critical allyship has been applied
to conceptualize health inequalities and help everyone who works
in health to take collective action on systems of inequality that im-
pact health.14 In the field of infection and ABR, research gaps in
understanding the impact of socioeconomic inequalities on out-
comes hinder the progress of critical allyship. This is despite the in-
clusion—in the 2018 WHO guidance on gender and equity in
antimicrobial resistance—of recommendations for stakeholders
developing NAPs, which acknowledge the persisting gaps in re-
search on how inequalities impact on ABR.6 It is also despite the
commitments made by the world’s governments to tackling
inequalities in health contained in the United Nations sustainable
development goals (SDGs).15 Goal 3 focuses on good health and
well-being, while many other goals also contribute to or are con-
nected to health. The other SDG goals include quality education,
gender equality, no poverty, and clean water and sanitation.
The SDGs incorporate the principle that we should ‘leave no one
behind’. While many countries were making progress towards a
number of the SDG targets before the COVID-19 pandemic,16 per-
sisting imbalances of power and resources continue to pose seem-
ingly intractable challenges and there are fears that the financial
damage caused by the COVID-19 pandemic may lead to a reversal
of the progress so far.17 There is growing recognition that a new
approach is needed, based on people- and patient-centred policies
that engage with communities, recognizing the need to better
understand the social construct of health inequities.18
In this review we explore the potential impact of socioeconomic
inequalities (uneven distribution of resources) and cultural inequi-
ties (avoidable imbalances due to cultural exclusion and poor gov-
ernance and policy-making) on ABR. We frame ABR as a social issue
influenced by intersecting sociocultural and economic factors,
which not only drive its emergence and spread but also create bar-
riers to tackling it. While we acknowledge the lack of comparable
data on the socioeconomic disparities and their association with
ABR, we consider the data that do exist so as to identify the research
and policy gaps that need to be addressed if we are to fully under-
stand the diverse impacts of ABR on different populations and pro-
vide solutions that are widely implementable and accessible.
Socioeconomic disparities and ABR from global to local
The limited research that exists on the relationship between socio-
cultural imbalances and inequities and ABR offers some stark find-
ings. An investigation of the social gradient in health in Europe
describes how structural factors, such as crowding, homelessness
and displacement, increase the risk of infections and ABR.19 These
conditions constrain the opportunities available for some people to
take measures that will reduce their risk of infectious diseases, as
well as limiting their timely access to appropriate healthcare when
needed. Affordable health services (including vaccination pro-
grammes) are critical to the prevention and spread of infectious
diseases, as are access to water, sanitation and hygiene (WASH).
The distribution of each of these is driven by upstream political, so-
cial and environmental factors.20 These basic resources remain
out of reach of millions of people worldwide. Living and working
conditions, combined with vulnerabilities shaped by individual
characteristics, such as ethnicity or migration status, influence the
risks of infection through poor living conditions and lack of access
to WASH, vaccination programmes and effective diagnostics and
antibiotics to treat infections.21
The interactions that lead to health inequalities relevant to in-
fectious diseases are complex and multifaceted. To take a few
examples, low vaccination coverage persists in marginalized com-
munities in many settings.22 Socioeconomic deprivation is a risk
factor for many infectious diseases, including TB and meningococ-
cal disease.19 In LMICs, the impact of poverty (encompassing
many sociocultural factors) on specific pathogens has been
reported, e.g. increased resistance amongst Streptococcus pneu-
moniae and Acinetobacter baumannii isolates and a 7-fold higher
infection rate.23 The consequences of the inter-relationship be-
tween poverty and ABR are dire, with one estimate suggesting
that ABR could push an additional 24 million people into extreme
poverty by 2030. Of the projected 10 million cases from drug-
resistant infections annually by 2050, the vast majority are esti-
mated to occur in LMICs of Africa and Asia.24
Sociocultural drivers of ABR
Much of health is decided outside of healthcare.25 Understanding
the experience of ABR from individuals differentially affected by
the social determinants of health is essential if we are to build pro-
grammes that are sustainable and meet the needs of entire popu-
lations. Power dynamics and hierarchies embedded and
translated within cultures impact health equity. Positionality of
individuals within society and culture is influenced by their gender
identity, class, religion and culture (Figure 1). These in turn influ-
ence individuals’ access to education, wealth and health, including
to WASH, and public health interventions such as vaccination pro-
grammes. Inequities in the representation within wider society
can act as both drivers for ABR and as barriers to efforts to tackle
ABR. For example, the division of power and hierarchies (including
by gender, socioeconomic status, race, ethnicity, class) across
structures within society can be predictors of health-providing and
health-seeking behaviours in the context of infection and ABR
(Figure 1). Understanding and addressing these dynamics will help
sustain efforts to meet the SDGs and develop contextually fit, cul-
turally sensitive and responsive interventions to tackle ABR across
different settings.
Sociocultural inequalities also act as barriers to the interven-
tions required to mitigate ABR, including influencing health-
providing behaviours. Though understudied, this is an important
consideration. Existing research has highlighted the hierarchies
within medical and surgical teams in hospitals that determine
antibiotic decision-making.26–28 Such hierarchies can get in the
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by making it more difficult to challenge senior doctors who are not
adhering to evidence-based guidelines and recommendations. In
the health workspace, historical exclusion and hierarchical struc-
tures can exclude key groups such as pharmacists and nurses in fa-
vour of doctors.29 Pharmacists receive training that allows them to
optimize antibiotic therapies while nurses make critical contribu-
tions to reducing risks of infection developing and spreading. The
exclusion of these groups from the decision-making process is like-
ly to lead to suboptimal patient care. The roles and responsibilities
of the allied healthcare professional groups are not fully under-
stood or integrated into the relevant policy and guidelines.30
The roles of patients and carers and the knowledge that they
bring to their care are also overlooked. Emerging evidence from
India has emphasized the critical yet overlooked role that carers
play in infection-related inpatient care (S. Surendran, E. Castro-
Sánchez, V. Nampoothiri, S. Joseph, S. Singh, C. Tarrant, A. Holmes
and E. Charani, unpublished data). The existing global infection
prevention and control (IPC) narrative considers patients as sole
decision-makers of their own care needs (S. Surendran, E. Castro-
Sánchez, V. Nampoothiri, S. Joseph, S. Singh, C. Tarrant, A. Holmes
and E. Charani, unpublished data). This overlooks an opportunity to
view the wider sociocultural context and the constellation of per-
sons who play a role in care and by extension decisions about IPC
and ABR.26 Furthermore, the ABR narrative is explained as a battle
between bugs and drugs, which overlooks human agency,6 lead-
ing to a partial and confusing narrative.31 For example, the dis-
course should perhaps be focused on antibiotic use and misuse,
which remains the key issue, rather than antimicrobial use and
misuse. Culture-sensitive IPC and ABR policies, which recognize the
communication needs of different populations and embrace the
roles that informal carers play, are urgently needed. We must gen-
erate knowledge and evidence to address the gaps in existing cul-
ture and practice and develop contextually fit solutions that will
facilitate change in organizations and society to impact healthcare
provider and user behaviours.
Gender and ABR
Gender inequalities also have consequences for ABR. Women often
face reduced access to financial resources, creating barriers to
healthcare, including screening for infection.32,33 Women also suf-
fer more from inadequate access to WASH,34 for example during
pregnancy and childbirth, when they are at particular risk of water-
borne pathogens leading to miscarriage, while lack of access to
clean water during childbirth increases the risk of maternal and
neonatal sepsis, cord infection and surgical site infections.34 Being
female is an independent risk factor for sepsis while, in community
settings, women receive significantly higher numbers of antibiotic
prescriptions than men.35–37 Recent literature indicates that the
gender of both healthcare provider and recipient may influence
not only the communication style but also antibiotic-prescribing
behaviours.38 A study from the Netherlands investigating antibiotic
prescribing for sore throat reported that female doctors were more
likely to adopt a ‘wait and see’ policy with female patients, whilst
male doctors were more likely to prescribe antibiotics.38
Inequalities that impact the infection-related healthcare needs of
individuals who do not identify as male or female and those who
have transitioned to a different gender remain largely
Sociocultural imbalances and their effect on ABR
As drivers of ABR
The needs and associated risks of specific
populations in society not addressed
Gaps in knowledge, awareness and literacy
Attitudes towards health, disease, infection
and ABR
Lack of access to health; over-, under-, mis-
use of antibiotics due to access issues
Lack of representation in policy and
decision-making
Campaigns not targeting diverse populations
Power dynamics and hierarchies influencing
adherence to desired behaviours
Lack of access to health; over-, under-, mis-
use of antibiotics due to access issues
As barriers to tackling ABR
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unaddressed. Recent studies have, however, reported a higher
than normal rate of surgical site infection and urethral complica-
tions in individuals undergoing gender reassignment surgery.39,40
Behaviours, roles and opportunities are based on different lev-
els of power.41 The majority of the workforce driving IPC are female
(nurses) and in stewardship teams, too, the pharmacy workforce
responsible for reviewing antibiotic prescriptions have a higher
female-to-male ratio. In LMICs community healthcare workers,
who are predominantly female, are critical to making health serv-
ices accessible to dispersed and diverse populations. In India,
Accredited Social Health Activists (ASHAs) and auxiliary nurse mid-
wives have major roles in infection prevention through delivering
vaccination programmes, early detection of infections in the com-
munity—including sepsis and pneumonia—and promoting safe
childbirth.42 Yet these community health workers must navigate
many challenges, including religious, cultural and gender norms,
which limit the work they can do.43 Furthermore, their training and
safety needs are rarely met while prevailing gender and social hier-
archies mean that their advice and recommendations are not con-
sistently adhered to.43
Education, communication and ABR
Socioeconomic status and ethnicity intersect with education.44 A
lack of formal education and awareness about infections amongst
the public has also been linked to ABR.23,45 Similarly, gaps in ABR-
related health literacy have been described together with the risk
these pose to behaviours that may lead to emergence of ABR and
infections, including hand hygiene practices and inappropriate
antibiotic use.46,47 Current ABR-related public health promotion
and education efforts do not address the inequalities in literacy
and education in their target populations, failing to reach those
who may be most vulnerable to the consequences of ABR.
Furthermore, the success of such campaigns in reaching the target
audience are rarely evaluated meaning there is no capacity for
learning from any potential impact they may have had.48
Health promotion amongst healthcare workers also needs to
recognize that individuals operate within social networks and are
influenced by sociocultural perspectives that need to be better
understood. The inconsistencies in education and training and en-
gagement on public health interventions impact healthcare work-
er infection-related behaviours. Inadequate training can lead to
lapses in IPC practices and inappropriate antibiotic prescribing, ad-
ministration and monitoring, which may all drive drug-resistant
infections. The impact of healthcare worker racial and ethnic dis-
parities on vaccine uptake has been reported not only for the influ-
enza vaccine, but more recently for vaccines developed for the
COVID-19 pandemic.49,50 Being able to address legitimate con-
cerns requires understanding the sociocultural beliefs that influ-
ence attitudes and behaviours. Only then can we develop
culturally sensitive, effective communication and build trust in
order to increase vaccination coverage and reduce the burden of
infection in healthcare worker populations.50
The COVID-19 pandemic and the widening inequalities
that impact ABR
The COVID-19 pandemic has exacerbated the existing inequalities
and will have long-lasting social and economic consequences
impacting health and well-being of populations for years to
come.51 This pandemic has shed a light on how sociocultural con-
structs and inequalities between different populations interact
resulting in significant disparities in health outcomes.52–54
Socioeconomic status, including income and living conditions,
impacts on the ability to adhere to public health interventions
seeking to prevent SARS-CoV-2 transmission. This is enhanced by
all the same factors that drive ABR, including lack of sustainable
access to health, education and social services, often in the setting
of weak health systems. All have negatively impacted socioeco-
nomically vulnerable populations during the COVID-19 pandemic.
The long-lasting legacies of health inequality on other pandem-
ics, such as HIV/AIDS for example, continue to this day.33 A nation-
al cohort study of patients with COVID-19 admitted to ICUs in the
UK has identified higher rates of intensive care admission and
death in areas with greatest socioeconomic deprivation.55 In the
USA, a recent study across three major cities has described the cor-
relation between high social vulnerability—measures include soci-
oeconomic status, household composition, minority status—with
high clusters of COVID-19 positivity, incidence and mortality.56
Longitudinally, the impact of the pandemic on women is predicted
to be significantly worse due to the disproportionate burden of un-
paid domestic and care work as well as less job security and pay.57
Whilst the global response is rightly focused on SARS-CoV-2,
secondary bacterial infections and both inappropriate and appro-
priate antibiotic use during this pandemic place additional burden
on already severely ill individuals and overstretched health sys-
tems.58 In LMICs, national programmes such as the directly
observed therapy (DOT) for TB treatment have been severely
affected due to disruption in essential services, with the countries
worst hit being Indonesia, South Africa, India and the Philippines,
all of which reported at least 25% reduction in TB treatment since
the beginning of the pandemic.59 Additionally, migrant labourers
and individuals from lower socioeconomic strata (the majority of
patients on DOT) returning to their villages and home cities during
the lockdown have also lost out on essential TB treatment.60
The reported use of azithromycin for treatment of COVID-19
will influence the resistance patterns of bacteria that are usually
treated with these agents. Another threat to the global efforts to
address ABR will be the increased use of community drug vendors
being used as the first point of care for the public in LMICs, as they
try to self-medicate and avoid high costs of consultation fees/user
fees, to procure however much of a course of antibiotics that can
based on the money they have. This is in part driven by the con-
venience of avoiding long queues in public hospitals but also the
lack of confidence in health systems due to perpetual stock-
outs.5,61 Reframing ABR as a social as well as a medical problem
would facilitate the efforts needed to address its underlying socio-
economic drivers and facilitate context-specific interventions to
mitigate them.
An intersectional framework for addressing ABR
Intersectional enquiry62,63 has been applied to many topics,
including in health, to better understand the complex interplay of
social hierarchies and constructs in intersecting and interactive
ways.64 Intersectionality hinges on understanding human beings
as shaped by the interaction of these different social constructs
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class, geography, religion, migration status and cultural trauma)
that interact within connected systems and structures of power
e.g. laws, policies and media.65 Recognizing these complex inter-
actions and dynamics allows for a better understanding of social
inequalities as well as their drivers allowing researchers, public
health policy-makers and governments to respond to them.18 To
date, most health systems research on intersectionality has been
from high-income settings. This is despite the fact that many of
the greatest challenges arising from inequalities in health are in
LMICs. In this context, it is deeply concerning that the UK govern-
ment has decided to cut its Official Development Assistance (ODA)
funds, threatening many international collaborative research proj-
ects focused on ABR.
Effective and sustainable responses to ABR require an under-
standing of how people of different races, classes and genders
seek, experience and provide infection-related healthcare and use
antibiotics. The questions that remain unanswered are: Is the inci-
dence and perceived or measurable impact of ABR the same for
everyone? Do any groups in society face greater or different risks of
exposure to ABR or more challenges in accessing, using and bene-
fiting from the information, services and solutions to tackle ABR?
These questions were posed in the WHO report on tackling ABR,
with a focus on gender identity and equity.6 To answer these ques-
tions, we need to apply an intersectional lens to research across
HICs and LMICs. To address ABR through an inclusive policy ap-
proach and transformative implementation lens, there needs to
be a proactive engagement with the prevailing inequities. At the
structural and policy level (Figure 2) there need to be greater
efforts to promote inclusivity in policy-agenda setting and
decision-making for ABR. This must include greater equity in global
representation across stakeholders, researchers and clinicians
from LMICs as well as from different populations within society.
The equity in representation and in division of funding for ABR re-
search must be supported by equitable healthcare systems, which
include vaccination programmes. The reach of structural and pol-
icy strategies in ABR will also be influenced by language, communi-
cation and advocacy efforts, which must recognize the culture-
and context-specific needs of populations. In order for them to be
used as a meaningful measure, qualitative and quantitative data
related to ABR must be disaggregated by gender, ethnicity and
socioeconomic vulnerability index.66
Interventions targeting ABR need to address transformative im-
plementation questions (Figure 2) to better understand the inter-
section of social constructs with ABR and infection. Accounting for
power dynamics in the context of ABR and infection will promote
inclusivity, enable greater participation in health and facilitate cap-
acity. This will help sustain efforts to meet the SDG goals and de-
velop contextually fit, culture-sensitive and responsive
interventions to tackle ABR across different settings. Building on
the WHO focus report on gender equity and ABR, we call for a
broader and inclusive approach to the research and implementa-
tion strategy to address this public health threat across HICs and
LMICs. This approach will give a platform to the narratives and
experiences of different groups of people within society as well as
different healthcare professional groups in relation to ABR and in-
fection management. This will be a step in the right direction to
assuring equitable access to optimized infection-related care.
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Equity in access to health, including vaccination programmes
How to ensure that the uptake of interventions in populations is equally distributed?
How can we ensure that the interventions addressing ABR reach different populations equally?
What interventions are needed to address differential health care user and provider behaviours related to ABR?
How can we develop indicators and data collection mechanisms for antibiotic use and infection by gender/ethnicity/deprivation
How do power relations and hierarchies across these constructs affect infection-related care-seeking and provision?
Do inequities in relation to social constructs affect behaviours of both health service users and providers?
What is the impact of prevalence and of ABR across populations?
Targeted public health messaging and interventions e.g. considering literacy, communication, language,
reach
Disaggregation of indicator data by gender/ethnicity/social deprivation
Prevailing socioeconomic disparities
Gender Race/Ethnicity/Caste IndigeneitySocioeconomic status Migration status
Figure 2. A framework to address ABR through an inclusive policy approach and transformative implementation lens that considers the impact of
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